PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Maturity in the US Artificial Heart Valve Market has Industry Participants Seeking New Opportunities - New analysis from Frost & Sullivan, U.S. Artificial Heart Valve Markets, reveals that revenues in this market totaled $519 million in 2005, and can reach $867 million in 2012
Maturity in the US Artificial Heart Valve Market has Industry Participants Seeking New Opportunities

 

NewswireToday - /newswire/ - San Antonio, TX, United States, 2007/02/06 - New analysis from Frost & Sullivan, U.S. Artificial Heart Valve Markets, reveals that revenues in this market totaled $519 million in 2005, and can reach $867 million in 2012.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

– While artificial heart valves have been in existence since 1950s, the past several years have seen significant upgrades in the materials and methodologies used in those devices.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the U.S. Artificial Heart Valve Markets, then send an e-mail to Melina Trevino - Corporate Communications with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.

“Recent advances in catheter technology have renewed focus on repair over replacement,” notes Frost & Sullivan Research Analyst Venkat Rajan. “Therefore, given the added physiological limitations of certain replacement valves, the majority of start up activity has been focused on the development of tissue valve repair products.”

Improvements to minimally invasive technologies and the rising prevalence of congestive heart failure and valve regurgitation have spurred a rise in the number of entrepreneurial annuloplasty designers. In the past an open heart procedure for heart valve was almost as risky as performing a valve replacement, therefore limiting application. However, with the introduction of minimally invasive beating heart products, heart valve repair has become a more feasible option.

Nevertheless, one of the biggest challenges to grow in a mature industry is executing strategies with enough magnitude to instigate a significant shift in the market. In nascent or developing medical device fields, a new product with advanced features or improved procedural efficiency is enough to warrant rapid market adoption. In mature markets such as this one, the opportunities to shift market perception about one’s brand name or a technology are quite limited.

“Growth in the U.S. heart valve market is being restrained by the absence of any recent paradigm shifting technologies that could otherwise facilitate market expansion,” says Rajan. “Another common barrier for growth is the regulatory and reimbursement requirements for defining qualified patients for interventional therapy.”

Given the importance placed on evidence-based medicine, it is crucial that market participants be able to profile their devices with detailed early stage and post market launch clinical data. Device thrombosis and durability are the biggest factors that affect device selection among clinicians, and being able to show low rates of complications requiring follow-up procedures are critical to persuading device adoption. Moreover, in established markets where there are no external threats, such as those for heart valves, head-to-head trials versus market competitors’ devices can be effective in shifting market share within a short time period.

U.S. Artificial Heart Valve Markets is part of the Medical Devices subscription, which also includes research services in the following markets: U.S. carotid and intracranial devices, U.S. cardiac rhythm management market and U.S. congestive heart failure devices market. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership service, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective, and combines ongoing analysis of markets, technologies, econometrics, and demographics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Maturity in the US Artificial Heart Valve Market has Industry Participants Seeking New Opportunities

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Melina Trevino 
210.247.2440 melina.trevino[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
The Float Space - Brisbane's First Float and Cryo Therapy Centre to Open This November
Thought Leaders Across the Healthcare Spectrum to Participate in Industry-Wide Survey
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Moriarty Physical Therapy of the Hudson Valley Expands with New Office in Lagrange, NY
Ultimate Medical Group Announces A New Regenerative Medicine Division
Dr. Amir Hanna Introduces New Medical Innovation Taking the Pain Out of Physical Therapy
Samitivej Children’s Hospital Transforms its Sukhumvit Campus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  NAKIVO, Inc.





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)